NK:IO

1 follower

‌

NK:IO is a biotech company that develops novel approaches to natural killer cell-mediated immunotherapy. The company develops both cell therapy and small molecule therapeutics primarily targeting cancer.

Industries

Biotechnology, Therapeutics

Employees

11-50

Links

Org chart

Mike Romanos

Co-founder & Non-executive Director (interim Ceo)

Mike Romanos

Collapse

Andrew Baxendale

Chief Operating Officer

Matthew Fuchter

Is A Co-founder And Director Of Nk:io

Prof Fuchter

Is A Co-founder And Director Of Nk:io

Teams

This company has no teams yet

Similar companies

NMD Pharma

4 followers

Isotopen Technologien München

1 follower

Apogee Therapeutics

1 follower

PrognomiQ

1 follower

Amgen

213 followers

Garuda Therapeutics

4 followers

Thermo Fisher Scientific

165 followers

Gilead Sciences

128 followers

Neuralink

60 followers

Alexion Pharmaceuticals

34 followers

Lonza

31 followers

Explore companies